RAD
Click for more information
6.67% 3.2¢ radiopharm theranostics limited

The issue I have is that they're progressing a multitude of...

  1. tonymcm
    62 Posts.
    lightbulb Created with Sketch. 12
    clock Created with Sketch.
    01/02/23
    15:27
    Post #: 66009088
    The issue I have is that they're progressing a multitude of assets (it is nice to have lots of options) whereas I wonder if it would be more productive to focus on the most compelling - make these your lead assets and try to get them "over the clinical line" and revenue generating via licence deals etc. I do wonder if they are juggling too much? Be interested in others' thoughts.
    RAD Price at posting: 13.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAD (ASX) to my watchlist
(20min delay)
Last
3.2¢ 		Change
0.002(6.67%) 		Mkt cap ! $33.83M
Open High Low Value Volume
3.2¢ 3.2¢ 3.1¢ $13.59K 433.0K

Buyers (Bids)

No. Vol. Price($)
3 194396 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 856772 4
View Market Depth
Last trade - 15.09pm 09/08/2024 (20 minute delay) ?
RAD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.